http://rdf.ncbi.nlm.nih.gov/pubchem/patent/SK-280665-B6
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_28f728a457c9b3df26f626ca3f50ba97 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L2-0023 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-00 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A01N1-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-26 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L2-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L2-00 |
| filingDate | 1993-02-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e55e191c141778eb0dabe20fa6d71d6a |
| publicationDate | 2000-05-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | SK-280665-B6 |
| titleOfInvention | PREPARATION FOR STABILIZING BLOOD PLASMA IN THE PROCESS |
| abstract | The invention relates to a composition intended to stabilise blood plasma during pasteurisation. The composition comprises a mixture of sorbitol, saccharose, calcium gluconate, trisodium citrate, lysine and arginine. Said composition is also intended to stabilise the blood plasma being whole or devoid of cryoproteins and makes it possible to pasteurise very large quantities of plasma (of the order of 60 litres). The invention also relates to a method of the blood plasma pasteurisation which can be characterised in that the plasma, prior to a heating phase thereof, is added with said composition and after the heating phase the mixture is devoid of sugars by dialysis against a buffer containing calcium gluconate, trisodium citrate, lysine and arginine. The pasteurised plasma obtained is intended for the therapeutic use. |
| priorityDate | 1992-02-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 78.